- Home
- LENZ vs SGML Comparison
LENZ vs SGML Comparison
Compare LENZ & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- SGML
- Stock Information
- Founded
- LENZ 2019
- SGML 2011
- Country
- LENZ United States
- SGML Brazil
- Employees
- LENZ N/A
- SGML N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- SGML Industrial Machinery/Components
- Sector
- LENZ Health Care
- SGML Industrials
- Exchange
- LENZ Nasdaq
- SGML Nasdaq
- Market Cap
- LENZ 819.1M
- SGML 879.0M
- IPO Year
- LENZ 2021
- SGML N/A
- Fundamental
- Price
- LENZ $29.94
- SGML $4.76
- Analyst Decision
- LENZ Strong Buy
- SGML Strong Buy
- Analyst Count
- LENZ 5
- SGML 2
- Target Price
- LENZ $41.80
- SGML $18.00
- AVG Volume (30 Days)
- LENZ 267.5K
- SGML 1.6M
- Earning Date
- LENZ 05-07-2025
- SGML 08-14-2025
- Dividend Yield
- LENZ N/A
- SGML N/A
- EPS Growth
- LENZ N/A
- SGML N/A
- EPS
- LENZ N/A
- SGML N/A
- Revenue
- LENZ N/A
- SGML $152,515,393.00
- Revenue This Year
- LENZ N/A
- SGML $43.73
- Revenue Next Year
- LENZ $544.79
- SGML $130.53
- P/E Ratio
- LENZ N/A
- SGML N/A
- Revenue Growth
- LENZ N/A
- SGML 0.36
- 52 Week Low
- LENZ $16.28
- SGML $4.52
- 52 Week High
- LENZ $38.93
- SGML $15.56
- Technical
- Relative Strength Index (RSI)
- LENZ 54.67
- SGML 33.31
- Support Level
- LENZ $27.91
- SGML $4.74
- Resistance Level
- LENZ $30.76
- SGML $5.29
- Average True Range (ATR)
- LENZ 2.09
- SGML 0.35
- MACD
- LENZ -0.14
- SGML 0.07
- Stochastic Oscillator
- LENZ 38.41
- SGML 17.02
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.